Target intelligence / Profile preview

Enterotoxigenic Escherichia coli colonization factor antigens (CFA) (CFA)

Target
CFA
Molecular classification
Adhesin, Bacterial surface protein, Other
01

Overview

Enterotoxigenic Escherichia coli (ETEC) colonization factor antigens (CFAs) are a diverse group of surface-associated proteins, primarily fimbriae or pili, that mediate the initial attachment of the bacteria to the host's small intestinal epithelium (NIH, 2022). This adherence is a critical first step in ETEC pathogenesis, allowing the bacteria to colonize the gut and subsequently release heat-labile (LT) and heat-stable (ST) enterotoxins that cause watery diarrhea (MDPI, 2024). There are over 25 identified CFAs, with CFA/I, CS1-CS6, and CS21 being among the most prevalent in human infections (NIH, 2015). Because blocking colonization can prevent the entire disease process, CFAs are primary targets for the development of vaccines and monoclonal antibodies (PLOS, 2022). Current therapeutic strategies, such as the ETVAX vaccine and anti-CfaE monoclonal antibodies, focus on inducing broad-spectrum immunity against multiple CFA types to overcome the significant antigenic diversity of ETEC strains (NIH, 2017).

Other names
Colonization factorsColi surface antigensCS antigensETEC adhesinsFimbrial colonization factorsPiliFimbriae
02

Mechanism of action

Inhibition of bacterial adhesion to intestinal epithelial cells by blocking colonization factor-mediated attachment to host enterocytes (NIH, 2022).

03

Biological functions

AdhesionColonizationBacterial aggregationBiofilm formation
04

Disease associations

InfectionDiarrheaTraveler's diarrhea
05

Safety considerations

Antigenic diversityStrain-specific immunityLack of cross-protection between different CFAsSerotype heterogeneity
06

Interacting drugs

ETVAX

3 more in the full profile.

07

Biomarkers

Anti-CFA IgA antibody titersAnti-CFA IgG antibody titers

Beyond the preview

Go deeper on Enterotoxigenic Escherichia coli colonization factor antigens (CFA) (CFA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Enterotoxigenic Escherichia coli colonization factor antigens (CFA) (CFA).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call